Research on treatments for cancer cachexia and side effects of standard cancer therapies using MSC-CM

Research on Treatments for Alleviating Cancer Cachexia and Side Effects of Standard Cancer Therapies Using Human-Derived Mesenchymal Stem Cell Conditioned Medium

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1051250161

Enrollment

100

Registered

2025-12-03

Start date

2025-12-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer cachexia and side effects of standard cancer treatment Cancer, Cachexia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Individuals who desire alleviation of cancer cachexia and side effects associated with cancer treatment. 2. Individuals for whom treatment with conditioned medium has been deemed appropriate by a physician. Inclusion criteria for patients are as follows: Patients meeting the following criteria are eligible: 1. Individuals aged 18 years or older. 2. Individuals with normal capacity to consent. 3. Individuals who have been provided with the informed consent document for this treatment, have received sufficient explanation, and are capable of providing written consent freely and voluntarily. 4. Individuals for whom the attending physician has recognized the necessity of treatment.

Exclusion criteria

Exclusion criteria: Individuals who meet any of the following conditions will be excluded: 1. Individuals who use narcotics or stimulants. 2. Individuals deemed inappropriate by the attending physician.

Design outcomes

Primary

Measure	Time frame
Condition of the patient, including the below as nesessary - Cancer markers - CT image diagnosis	—

Contacts

Public ContactYoichi Kato

Shin Yokohama Kato Clinic

kato@katoclinic.info+81-90-1725-1005

Outcome results